The TNFSF13B variant, resulting in an overexpression of the B cell activating factor (BAFF), was found to be associated with MS and SLE in a genome-wide association study in Sardinia (107) and can help to explain the higher frequencies of myasthenia gravis. Here, TNFSF13B is linked to myasthenia gravis.